17 Jiang Jiang J J Feng Feng X X Zhou Zhou W W Wu Wu Y Y Yang Yang Y Y MiR-128 reverses the gefitinib resistance of the lung cancer stem cells by inhibiting the c-met/PI3K/AKT pathway MiR-128 reverses the gefitinib resistance of the lung cancer stem cells by inhibiting the c-met/PI3K/AKT pathway Oncotarget Oncotarget 2016 2016 7 7 73188 73188 73199 73199 https://doi.org/10.18632/oncotarget.12883 https://doi.org/10.18632/oncotarget.12883 https://doi.org/10.18632/oncotarget.12883 27690301 27690301. The gene discussed is AKT1; the disease is lung carcinoma.